Ph.D. in Reproductive Toxicology, post-doc at Hoffmann La Roche in U.S.A. working on retinoid (Vitamin A) biology, returned to UK to work at Glaxo Wellcome developing cell-based assay development for screening purposes then AstraZeneca. In 2011 I was one of the founding entrepreneurs of Aurelia Bioscience, a CRO in the UK. We develop bioassays for clients to test compounds and biologics.
Not yet a member? Become a member FREE to:
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>